UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem's Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg. UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we furnish herewith the intimation about the loss / misplacement of Share Certificate(s), as received from Link Intime India Pvt Ltd, the Registrar & Share Transfer Agents of Company. UNICHEM LABORATORIES LTD. - 506690 - Confirmation Of Notice To Shareholders Of The Company Holding Shares In Physical Form For Updating Of Details Like PAN, KYC And Nomination Etc.
Confirmation of Notice to shareholders of the Company holding shares in physical form for updating of details like PAN, KYC and Nomination etc. UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem's Divalproex Sodium Extended-Release Tablets USP, 250 mg and 500 mg. UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we furnish herewith the intimation about the loss / misplacement of Share Certificate(s). UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Financial Results for the quarter and nine months ended December 31, 2021 published in the newspapers on January 31, 2022. UNICHEM LABORATORIES LTD. - 506690 - Board Meeting Outcome for Approval Of Unaudited Results (Standalone & Consolidated) For The Quarter And Nine Months Ended 31.12.2021.
Approval of Unaudited results (Standalone & Consolidated) for the quarter and nine months ended 31.12.2021. UNICHEM LABORATORIES LTD. - 506690 - Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2021.
UNICHEM LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2022 ,inter alia, to consider and approve Unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2021. UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation about the loss / misplacement of Share Certificate(s) UNICHEM LABORATORIES LTD. - 506690 - Shareholding for the Period Ended December 31, 2021
Unichem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here